INTRODUCTION
============

The adenomatous polyposis coli (APC) tumor suppressor is the most commonly mutated gene in colorectal cancer ([@B36]). The APC protein is involved in many of the fundamental processes that govern normal gut epithelium. It is best known for controlling the Wnt/β--catenin pathway, where it regulates β-catenin levels, thereby regulating the transcriptional activity of T-cell factor (TCF)/lymphoid-enhancing factor (LEF) transcription factors ([@B4]). APC also contributes to the regulation of cytoskeletal proteins ([@B27]). Importantly, *APC* is mutated in the human syndrome familial adenomatous polyposis (FAP). FAP patients are heterozygous for *APC* and develop hundreds of polyps in their gut that invariably become cancerous if left untreated ([@B18]; [@B14]). The progression to malignancy probably involves inflammation and hypoxia ([@B32]; [@B37]).

Hypoxia is an important stimulus for tumor angiogenesis and growth ([@B32]; [@B16]). The transcriptional response to hypoxia is mainly controlled by the hypoxia-inducible factor (HIF) system ([@B2]). HIF is a heterodimeric transcription factor composed of α and β subunits. Although HIF-1β is constitutively expressed, HIF-α subunits are extremely labile at normal oxygen levels. HIF-1α levels respond to oxygen through posttranslational hydroxylation, which is catalyzed by a class of 2-oxoglutarate dioxygenases called prolyl-hydroxylases (PHDs). Hydroxylation of specific proline residues in the oxygen-dependent degradation domain of HIF-1α targets it for ubiquitination by the Von Hippel Lindau system and subsequent degradation by the proteasome ([@B13]; [@B6]). When oxygen levels are reduced, or cofactors such as iron ions are not available, PHD activity is inhibited so that HIF-1α levels increase, translocates into the nucleus, and transactivates its target genes. Among the HIF-1α targets are PHD2 and PHD3, which create a negative feedback loop for the system ([@B29]; [@B34]).

The HIF-1α gene is under the control of nuclear factor (NF)-κB ([@B17]; [@B38]; [@B43]) and the chromatin remodelling complex SWI/SNF ([@B20]). NF-κB is the collective name for a family of important transcription factors that control many cellular processes, such as apoptosis and proliferation (reviewed in [@B33]). Impairment of NF-κB results in the loss of HIF-1α mRNA ([@B38]; [@B43]), which reduces HIF-1α levels in response to hypoxia or proteasomal inhibition ([@B38]; [@B43]). This causes inappropriate cellular responses to hypoxia in cells lacking normal NF-κB ([@B43]; [@B20]).

HIF-1α and β-catenin are also functionally connected ([@B19]; [@B24]). Specifically, HIF-1α can interfere with coactivation of TCF/LEF transcription mediated by β-catenin. Furthermore, β-catenin can bind and regulate NF-κB activity ([@B9], [@B10]; [@B12]). Despite the established relationship between HIF-1α, NF-κB, and Wnt/β-catenin, a link between APC and HIF-1α has not been investigated.

Here, we report functional cross-talk between HIF-1α and APC at the transcriptional level. Depletion of HIF-1α results in increased APC mRNA and protein. Consistent with direct transcriptional repression of APC by HIF-1α, we discovered a hypoxia-responsive element (HRE) in the APC promoter and demonstrate that hypoxia induces HIF-1α binding to this site. Importantly, hypoxia promotes a reduction in APC mRNA and protein in different cells suggesting that suppression of APC by hypoxia may be involved in increased survival in hypoxic conditions in tumors with wild-type APC. Interestingly, APC depletion results in increased HIF-1α levels and activity. This increase is mediated by NF-κB and requires regulation of β-catenin by APC. Our results also suggest that cells lacking APC are adapted to hypoxia and hence have a survival and proliferative advantage under hypoxic conditions. This could be an important factor in the progression of colorectal tumors.

MATERIALS AND METHODS
=====================

Cells
-----

U2OS were obtained from American Type Culture Collection (Manassas, VA). HCT-116 (parental, HAβ 85, and HAβ 18) were a kind gift from Prof. T. Waldman (Georgetown University, Washington DC). SW480 and DLD-1 ([@B23]) were grown in DMEM (Lonza Verviers, Verviers, Belgium) supplemented with 10% fetal bovine serum (Invitrogen, Paisley, United Kingdom), 50 U/ml penicillin (Lonza Verviers), and 50 μg/ml streptomycin (Lonza Verviers) for no \>30 passages. U2OS-HRE luciferase cells were a kind gift from Dr. Margaret Ashcroft (University College, London, UK) and have been described previously ([@B3]; [@B20]).

Small Interfering RNA (siRNA) Transfection
------------------------------------------

siRNA duplex oligonucleotides were synthesized by Eurofins MWG Operon (Huntsville, AL) and transfected using Oligofectamine (Invitrogen) and INTERFERin (Polyplus, Illkirch, France) as per the manufacturer\'s instructions. siRNA sequences are as follows: control, AACAGUCGCGUUUGCGACUGG ([@B43]); (a) HIF-1α-CUGAUGACCAGCAACUUGA ([@B43]) and (b) HIF-1α-GGAAUUGGAACAUUAUUAC; APC (Dharmacon RNA Technologies, Lafayette, CO) ([@B11]); and RelA, GCUGAUGUGCACCGACAAG ([@B1]). Unless stated, HIF-1α sequence (a) was mostly used throughout this study.

Mouse Tissue and Staining
-------------------------

Tissue samples of mouse small intestine were a kind gift from Dr. Owen Sansom (CRUK Beatson Institute, Glasgow, United Kingdom). Tissue was harvested from (*AhCre*^+^ *Apc^fl/fl^*) mice 4 d after APC deletion from the intestinal crypt and stem cells ([@B40]). APC was deleted from the intestinal epithelium by inducing Cre-mediated recombination with β-naphtoflavone as described previously ([@B40]), and mice were treated with 20 mg/kg i.p. Taxol (paclitaxel, Mayne Pharma, Salisbury South, SA. Australia), a microtubule stabilizer 3 h (h) before tissue was harvested. Taxol treatment arrests cell in mitosis and makes APC-depleted regions of the gut more visible. Gut tissue was fixed in 4% paraformaldehyde and processed into wax blocks. Dewaxed sections were placed in citrate buffer and antigen retrieved in a pressure cooker. After cooling overnight, slides were rinsed in phosphate-buffered saline (PBS) 2 × 10 min and permeabilized with 1% Triton X-100 in PBS for 20 min. After a rinse in PBS, slides were blocked for 2 h with MAXblock (Active Motif, Carlsbad, CA) at room temperature. Slides were incubated with CA9 antibody at a dilution of 1:500 in working buffer (WB: 0.1% bovine serum albumin, 0.3% normal goat serum, and 0.2% Triton X-100 in PBS, pH 7.4) overnight at 4°C. After 5 × 5-min rinses in WB, slides were incubated in secondary antibody goat ant-rabbit Alexa 647 (Invitrogen; 1:250) for 1 h at room temperature. After 5 × 5-min rinses in WB and 3 × 5-min rinses in PBS, cell nuclei were counterstained with 4,6-diamidino-2-phenylindole in PBS. After rinsing in PBS, sections were mounted in Prolong Gold (Invitrogen). Slides were imaged on a DeltaVision Core microscope system (Applied Precision, Seattle, WA), and images were deconvolved using softWoRx (Applied Precision).

Hypoxia Inductions and MG132 Treatment
--------------------------------------

Cells were incubated at 1% O~2~ in an InVIVO 300 hypoxia workstation (Ruskin Technologies, Bridgend, United Kingdom). Cells were lysed for protein and RNA extraction in the workstation to avoid reoxygenation. MG132 (Merck Biosciences, Darmstadt, Germany) at 50 μM was added 3 h before cell harvesting.

Chromatin Immunoprecipitation (ChIP)
------------------------------------

Proteins were cross-linked with formaldehyde for 10 min. Then, 0.125 mol/l glycine was added, and cells were washed with PBS. Cells were lysed with lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin, and 1 mg/ml aprotonin), followed by sonication and centrifugation. The supernatant was precleared with sheared salmon sperm DNA and protein G-Sepharose beads (Sigma Chemical/Generon, Berkshire, UK). Supernatant was incubated with specific antibodies overnight and then with protein G-Sepharose beads for 1 h. After extensive wash step, the complexes were eluted with buffer (100 mmol/l NaHCO~3~ and 1% SDS) and incubated with proteinase K. DNA was purified using polymerase chain reaction (PCR) purification kit (QIAGEN/National Blood Service, Burmingham, United Kingdom). PCR was performed using the following primers: CA9 promoter (HRE), forward, GACAAACCTGTGAGACTTTGGCTCC and reverse, AGTGACAGCAGCAGTTGCACAGTG; and APC HRE2, forward, TAGGGCTAGGCAGGCTGTG and reverse, CTGCACCAATACAGCCACAT.

Colony Formation Assay
----------------------

Cells were plated at 5000 or 10,000 cells per well of six-well plates and grown for 8 d after which cells were washed with PBS and stained with crystal violet. Plates were scanned, and number of colonies was counted using ImageJ software (National Institutes of Health, Bethesda, MD).

Antibodies
----------

Antibodies used were as follows: HIF-1α (MAB1536, R&D Systems), CA9 (NB100-417; Novus Biologicals. Littleton, CO), β-actin (A5441; Sigma Chemical), Glut3 (RB-9096; Neomarkers, Fremont, CA), RelA (sc-372; Santa Cruz Biotechnology, Santa Cruz, CA), phospho-Ser536 RelA (3033; Cell Signaling Technology, Danvers, MA), phospho-Ser32/36 inhibitor of κB (IκB-α) (9246; Cell Signaling Technology), IκB-α (4812; Cell Signaling Technology), HIF-1β (3718; Cell Signaling Technology), APC ([@B31]), α-tubulin (T9026; Sigma Chemical), β-catenin (4270; Cell Signaling Technology; [@B11]), BNIP3 (Ab10433; Abcam, Cambridge, United Kingdom), Chk1 (sc-8408; Santa Cruz Biotechnology), cyclin D1 (2926; Cell Signaling Technology), and LC3B (2775; Cell Signaling Technology or sc-16756; Santa Cruz Biotechnology). ChIP antibodies used were as follows: HIF-1α (sc-10790; Santa Cruz Biotechnology), HIF-1β (sc-5580; Santa Cruz Biotechnology), acetyl-H3 (06-599; Millipore, Billerica, MA), and polymerase II (Pol II) carboxy-terminal domain (sc-47701; Santa Cruz Biotechnology).

RNA, cDNA, and Quantitative (q)PCR
----------------------------------

Total RNA was extracted using Invisorb spin cell RNA (Invitek, Hayward, CA) or PeqLab Gold RNA extraction kit, according to the manufacturer\'s directions. RNA was converted to cDNA using Quantitect reverse transcription kit (QIAGEN). Brilliant II SYBR Green kit (Stratagene/Agilent Technologies, Santa Clara, CA) was used, and samples analyzed using a Mx3005P qPCR machine and software (Stratagene/Agilent).

qPCR Oligonucleotides Sequences
-------------------------------

qPCR oligonucleotides sequences were as follows: actin, forward, CTGGGAGTGGGTGGAGGC and reverse, TCAACTGGTCTCAAGTCAGTG; RelA, forward, CTGCCGGGATGGCTTCTAT and reverse, CCGCTTCTTCACACACTGGAT; HIF-1α, forward, CATAAAGTCTGCAACATGGAAGGT and reverse, ATTTGATGGGTGAGGAATGGGTT; APC, forward, TGTCCCTCCGTTCTTATGGAA and reverse, TCTTGGAAATGAACCCATAGGAA; CA9, forward, CTTTGCCAGAGTTGACGAGG and reverse, CAGCAACTGCTCATAGGCAC; Glut3, forward, CAATGCTCCTGAGAAGATCATAA and reverse, AAAGCGGTTGACGAAGAGT; and ADM, forward, GGAAGAGGGAACTGCGGATGT and reverse, GGCATCCGGACTGCTGTCT.

Statistical Analysis
--------------------

Analysis of variance and Student\'s *t* tests were performed on the means, and p values were calculated (\*p ≤ 0.050, \*\*p ≤ 0.010, and \*\*\*p ≤ 0.005.

Other Experimental Procedures
-----------------------------

Immunoblots, transfections, and luciferase assays have been described previously ([@B39]; [@B41]; [@B11], and references therein).

RESULTS
=======

APC Is Repressed Directly by HIF-1α during Hypoxia
--------------------------------------------------

Hypoxia is a common feature of most solid tumors and is thought to contribute to tumor progression and therapy evasion ([@B16]). In colorectal cancer, APC mutation occurs early and subsequent genetic alterations drive tumorigenesis. Given the importance of hypoxia in cancer, we investigated whether hypoxia modulated APC function in cells. Immunoblotting protein from a variety of cell lines after hypoxia treatment showed that hypoxia resulted in reduced APC protein in all the cells tested regardless of APC mutation status ([Figure 1](#F1){ref-type="fig"}A). In addition, in U2OS cells, which express wild-type APC, hypoxia resulted in increased β-catenin stabilization ([Figure 1](#F1){ref-type="fig"}A).

![HIF-1α represses APC gene expression. (A) U2OS, HCT-116. Haβ18, Haβ85, SW480, and DLD-1 cells were exposed to 1% O~2~ for 24 h before harvest. Whole cell lysates were analyzed by immunoblot blot using the indicated antibodies. (B) U2OS cells were exposed to 1% O~2~ for the indicated periods before total RNA or whole cell lysates extraction. RT-qPCR for APC was performed with actin as a reference. The graph depicts the mean plus SD of a minimum of three independent experiments performed in duplicate. Whole cell lysates were analyzed by immunoblot blot using the indicated antibodies. (C) U20S, HCT-116, and HAβ18 cells were transfected with control and HIF-1α siRNA oligonucleotides (a and b) for 48 h before total RNA extraction. RT-qPCR for APC and HIF-1α was performed with actin as a reference gene. The graph depicts the mean plus SD of a minimum of three independent experiments performed in duplicate. (D) U2OS cells were transfected with control, APC, and HIF-1α siRNA oligonucleotides for 48 h. Cells were exposed to 1% O~2~ for 24 h before harvest. Whole cell lysates were analyzed by Western blot using the indicated antibodies. Asterisk (\*) indicates the level of significance. \*p \< 0.05, \*\*p \< 0.01, and \*\*\*p \< 0.005.](zmk0211096350001){#F1}

To determine whether hypoxia changed APC gene transcription, we used reverse transcriptase (RT) followed by qPCR to measure APC mRNA at different times after hypoxia exposure ([Figure 1](#F1){ref-type="fig"}B). Our analysis revealed that hypoxia results in decreased APC mRNA levels in a time-dependent manner corresponding to HIF-1α stabilization ([Figure 1](#F1){ref-type="fig"}B and Supplemental Figure 1A).

A key response to hypoxia is activation of the transcription factor HIF-1α. To determine whether hypoxia-mediated APC inhibition was HIF-1α dependent, we depleted HIF-1α by using siRNA and measured APC mRNA levels ([Figure 1](#F1){ref-type="fig"}C). HIF-1α depletion in all cells tested using two different siRNA oligonucleotides, resulted in increased levels of APC mRNA in normoxia ([Figure 1](#F1){ref-type="fig"}C). Similar results were also observed in hypoxia (Supplemental Figure 1B). This correlated with increased APC protein in cells depleted of HIF-1α ([Figure 1](#F1){ref-type="fig"}D). Together, these results indicate that HIF-1α represses APC gene expression.

APC Is a Direct HIF-1α Target
-----------------------------

Hypoxia results in reduced expression of APC, and HIF-1α depletion by RNA interference increased APC mRNA and protein levels. To determine whether APC is a direct target of HIF-1α, we analyzed the APC promoter region using MattInspector, which revealed two putative HIF-1α binding sites located in the APC promoter (accession [U02509](U02509)). ChIP using a HIF-1α antibody revealed specific and inducible HIF-1α binding to region 2 but not the putative HIF-1α binding site 1 ([Figure 2](#F2){ref-type="fig"}A; data not shown). The CA9 promoter was used as a positive control. Hypoxia induces rises in HIF-1α protein due to increased stability. As such, it was possible that the observed HIF-1α recruitment to these promoters was merely a consequence of increased protein levels in the cell. To rule out this possibility, we performed ChIP experiments with the HIF-1α binding partner HIF-1β, whose levels are unaltered by hypoxia exposure ([Figure 2](#F2){ref-type="fig"}B). The results clearly demonstrate that hypoxia induces an increased recruitment of HIF-1β to both the CA9 and the APC promoters ([Figure 2](#F2){ref-type="fig"}B), further confirming a direct role for the HIF-1 transcription factor in the repression of the APC promoter. Importantly, binding of HIF-1α to the APC promoter was accompanied by hallmarks of repressed transcription, specifically a reduction in the recruitment of RNA Pol II ([Figure 2](#F2){ref-type="fig"}C) and in the levels of AcH3 after exposure to hypoxia ([Figure 2](#F2){ref-type="fig"}D and Supplemental Figure 2). These experiments revealed that hypoxia-activated HIF-1α represses the APC promoter directly by occupying a specific site on the APC promoter revealing APC as a novel HIF-1α target and providing crucial insight into the poorly understood transcriptional control of this important tumor suppressor.

![APC is a direct HIF-1α target. (A) ChIP analysis for HIF-1α binding to the APC and CA9 promoters. U2OS cells were exposed to 1% O~2~ for the indicated periods before fixation and lysis. HIF-1α-bound DNA was amplified with specific primers spanning the annotated HRE region on the CA9 and the putative HRE at the APC promoter. Rabbit immunoglobulin G (IgG) was used as a control for the immunoprecipitation. Input represents 10% of the starting material used per immunoprecipitation (IP). (B) ChIP analysis for HIF-1β binding at the APC and CA9 promoters. U2OS cells were exposed to 1% O~2~ for 24 h before fixation and lysis. HIF-1β--bound DNA was amplified with specific primers spanning the annotated HRE region on the CA9 and the putative HRE at the APC promoter. Rabbit IgG was used as a control for the immunoprecipitation. Input represents 10% of the starting material used per IP. (C) ChIP for AcH3. (D) Polymerase II at the APC HRE site. Cells were treated and processed as described in B. Rabbit IgG was used as a negative control. APC HRE site was amplified using specific PCR primers. Inputs represent 10% of starting material used in each IP.](zmk0211096350002){#F2}

APC Depletion Increases HIF-1α Message, Protein, and Transcriptional Activity
-----------------------------------------------------------------------------

To determine the effect of the APC tumor suppressor on the activity of HIF-1α, we performed luciferase reporter assays in a U2OS reporter cell line that has been used extensively to measure HIF-1α transcriptional activity ([@B3]; [@B20]). Cells were transfected with previously validated siRNA oligonucleotides that target APC ([@B11]) and HIF-1α ([@B20]). In addition, cells were exposed to 1% O~2~ for 24 h before harvest. As expected, depletion of HIF-1α abolished hypoxia-induced luciferase activity, confirming loss of HIF-1α ([Figure 3](#F3){ref-type="fig"}A). Depletion of APC, in contrast, resulted in a significant increase in HIF-1α activity ([Figure 3](#F3){ref-type="fig"}A).

![APC depletion increases HIF-1 levels and activity. (A) U2OS-HRE luciferase cells were transfected with the indicated siRNA oligonucleotides. Where indicated, cells were exposed to 1% O~2~ for 24 h before harvest. Luciferase activity was analyzed 48 h posttransfection. Graph depicts the mean plus SD of a minimum of two independent experiments performed in duplicate. (B) U2OS cells were transfected with control and APC siRNA oligonucleotides for 48 h before total RNA extraction. Where indicated, cells were exposed to 1% O~2~ for 24 h. After cDNA synthesis, qPCR was performed for APC and HIF-1α mRNA. Levels were normalized to actin mRNA, and the graph depicts the mean plus SD of a minimum of three independent experiments performed in duplicate. (C) U2OS cells were transfected with siRNA oligonucleotides as indicated and exposed or not to 1% O~2~ for 24 h before harvest. Whole cell lysates were analyzed by Western blot to detect the levels of APC, HIF-1α, and the HIF-1α target Glut3. Actin and HIF-1β were used as loading controls. (D) U2OS cells were treated as described in B, and qPCR was performed for the HIF-1α target genes as indicated. Asterisk (\*) indicates the level of significance. \*p \< 0.05, \*\*p \< 0.01, and \*\*\*p \< 0.005.](zmk0211096350003){#F3}

To establish whether the mechanism responsible for increased HIF-1α transcriptional activity in response to APC loss involved transcriptional changes, APC levels were depleted using siRNA oligonucleotides and total RNA was extracted. RT-qPCR was used to measure APC and HIF-1α mRNA levels. APC siRNA reduced APC mRNA significantly in U2OS cells ([Figure 3](#F3){ref-type="fig"}B). Surprisingly, this reduction in APC was accompanied by a significant increase of HIF-1α mRNA ([Figure 3](#F3){ref-type="fig"}B). These effects also were observed after hypoxia treatment ([Figure 3](#F3){ref-type="fig"}B). Slight changes in HIF-1α mRNA can cause significant changes in HIF-1α protein levels and activity ([@B43]; [@B20]), so we determined whether APC depletion also increased HIF-1α protein and its endogenous target genes. U2OS cells were transfected with APC siRNA and exposed to 1% O~2~ for 24 h before harvest. Immunoblotting showed that APC depletion produced an increase in basal levels of HIF-1α and a further increase in hypoxia-stabilized HIF-1α protein ([Figure 3](#F3){ref-type="fig"}C). Similar results were observed when cells were treated with the proteasome inhibitor MG132, where APC depletion resulted in higher HIF-1α protein levels (Supplemental Figure 3A). In addition, the Glut3 protein (a known HIF-1α target) was also increased when APC was absent ([Figure 3](#F3){ref-type="fig"}C). Importantly, transcripts of several HIF-1α target genes such as Glut3, CA9, PHD2, and ADM also were increased both in normoxia and hypoxia when APC was depleted ([Figure 3](#F3){ref-type="fig"}D and Supplemental Figure 3B). These results establish that APC depletion leads to HIF-1α activation.

APC Modulation of HIF-1α Requires Wild-Type APC
-----------------------------------------------

To determine whether our findings were also evident at the organism level, we investigated the effects of APC depletion in vivo. Using tissue harvested from *AhCre*^+^ *Apc^fl/fl^* mice 4 d after APC deletion from the intestinal crypt, we visualized the levels of the HIF-1α target CA9 ([@B40]). In wild-type tissue, CA9 was localized to the cell cortex in differentiated cells and only weakly detectable in crypts ([Figure 4](#F4){ref-type="fig"}A). APC depletion in cells toward the base of the crypt resulted in disorganized epithelium ([@B40]) with increased CA9 staining indicating higher HIF-1α activity ([Figure 4](#F4){ref-type="fig"}A). Because Cre-activation and thus APC depletion is initiated in the proliferative compartment of the crypt, cells toward the tip of the villus in these sections are still wild type for APC ([@B40]) and, like control tissue, they showed only weak staining for CA9. These results indicate that APC depletion results in activation of HIF-1α in the context of a tissue confirming our biochemical data.

![Depletion of APC increases HIF-1α activity in situ. (A) CA9 staining of wild-type (WT) and APC-depleted mouse small intestine. Maximum intensity projections of widefield, deconvolved images show cortical localization of CA9 in crypts from WT tissue (arrowhead), except in Paneth cells at the base of the crypt, which show little or no staining. APC-depleted cells toward the base of the crypt/villus axis (arrow) form a disorganized epithelium and elevated CA9 homogenously in the cytoplasm. Because Cre-activation and thus APC depletion only occurs in the proliferative compartment of the crypt, the same tissue section also shows cells toward the tip of the villus (arrowhead) that are wild type for APC, and, like control tissue, show only weak staining for CA9. Bars, 20 μm. (B) SW480 and DLD-1 cells were transfected with control and APC siRNA oligonucleotides and treated where indicated with 50 μM MG132 for 3 h before harvest. Whole cell lysates were analyzed by Western blot using the indicated antibodies.](zmk0211096350004){#F4}

APC is mutated in the majority of colorectal cancers and these tumors often have elevated HIF-1α protein levels ([@B15]). To establish whether mutant APC can still regulate HIF-1α, we determined whether depletion of mutant APC also resulted in increased HIF-1α levels. For this purpose, we analyzed SW480 and DLD-1 cells. Both express only truncated, mutant APC ([@B23]; [Figure 4](#F4){ref-type="fig"}B). Because HIF-1α protein is usually kept at low levels by O~2~-dependent proteasomal degradation, any changes in HIF-1α mRNA can be visualized using the proteasome inhibitor MG132 ([@B3]; [@B20]). When APC was depleted in either of these cell types, no changes in HIF-1α protein were detected ([Figure 4](#F4){ref-type="fig"}B), suggesting that mutant APC cannot modulate HIF-1α levels.

APC Modulation of HIF-1α Requires Wild-Type β-Catenin
-----------------------------------------------------

One of the main functions of APC is to limit Wnt/β--catenin signaling, so it was important to determine whether increases in HIF-1α induced by depletion of APC were due to changes in β-catenin. Using a panel of isogenic HCT-116 cells that express either mutant (stabilized and thus not sensitive to APC regulation) and wild type β-catenin (parental), or only wild-type β-catenin (HAβ85), or only mutant (HAβ18) β-catenin, we repeated the depletion of APC, treated with hypoxia, and measured HIF-1α levels under these conditions. RT-qPCR analysis revealed that although in parental and mutant only β-catenin (HAβ18) cells, APC depletion did not cause a change in HIF-1α mRNA, depletion of APC in wild-type only β-catenin (HAβ85) cells resulted in increased HIF-1α mRNA ([Figure 5](#F5){ref-type="fig"}A). In addition, we investigated whether increased HIF-1α mRNA translated to increased HIF-1α activity ([Figure 5](#F5){ref-type="fig"}B). In cells containing wild-type β-catenin, depletion of APC resulted in significant increases in HIF-1α target genes such as Glut3, CA9, ADM, PHD2, and BNIP3 ([Figure 5](#F5){ref-type="fig"}B and Supplemental Figure 4). However, in the presence of mutant β-catenin, depletion of APC did not cause any significant changes in HIF-1α target genes ([Figure 5](#F5){ref-type="fig"}B and Supplemental Figure 4). Additional analysis revealed that APC depletion in β-catenin wild-type cells resulted in more stabilized HIF-1α after MG132 treatment ([Figure 5](#F5){ref-type="fig"}C). Together, these results indicate that APC modulation of HIF-1α mRNA requires intact regulation of β-catenin by APC.

![Increased HIF-1α after APC depletion requires wild-type β-catenin. (A) HCT-116 (parental, mutant, and wild-type β-catenin), HAβ85 (wild-type β-catenin), and HAβ18 (mutant β-catenin) were transfected with control or APC siRNA oligonucleotides for 48 h before RNA extraction and exposed or not to 1% O~2~ for 24 h. RT-qPCR was performed for APC and HIF-1α, with actin used as a normalizing gene. The graph depicts mean plus SD of a minimum of three independent experiments performed in duplicate. (B) HAβ85 (wild-type β-catenin) and HAβ18 (mutant β-catenin) were transfected with control or APC siRNA oligonucleotides for 48 h before RNA extraction and exposed or not to 1% O~2~ for 24 h. RT-qPCR was performed for the indicated HIF-1α target genes. The graph depicts mean plus SD of a minimum of three independent experiments performed in duplicate. Asterisk (\*) indicates the level of significance. \*p \< 0.05, \*\*p \< 0.01, and \*\*\*p \< 0.005. (C) HAβ85 (wild-type β-catenin) and HAβ18 (mutant β-catenin) were transfected with control, APC, or HIF-1α siRNA oligonucleotides and treated where indicated with 50 μM MG132 for 3 h before harvest. Whole cell lysates were analyzed by immunoblot using the indicated antibodies. ImageJ software was used to quantify band intensity.](zmk0211096350005){#F5}

APC/β-Catenin Modulation of HIF-1α Depends on NF-κB
---------------------------------------------------

We showed previously that the HIF-1α gene is under the tight control of NF-κB ([@B43]; [@B20]). NF-κB is usually retained in the cytoplasm by the action of a family of proteins called IκBs. On activating stimuli such as tumor necrosis factor (TNF)-α, IκB is degraded so NF-κB can translocate into the nucleus and active its targets ([@B33]). The NF-κB response in the isogenic cell lines we used to investigate the role of β-catenin in modulating of HIF-1α was described recently ([@B12]). The Geller group demonstrated that Wnt/β-catenin regulates cytokine-induced NF-κB activation ([@B12]). We analyzed NF-κB activation in response to TNF-α in these cells by using a biochemical fractionation assay and immunofluorescence, to measure RelA translocation from the cytoplasm into the nucleus (Supplemental Figure 5, A and B). We confirmed that in wild-type β-catenin cells, TNF-α induced p65/RelA nuclear translocation, whereas in the parental HCT-116 cells and mutant β-catenin only cells, RelA nuclear translocation was attenuated (Supplemental Figure 5, A and B). In addition, the level of phosphorylated RelA at Ser 536, a marker of NF-κB activity, was also higher in wild-type β-catenin cells. Interestingly, phosphorylation of the NF-κB inhibitory protein IκB-α also was diminished in β-catenin mutant cells (Supplemental Figure 5C).

We next investigated whether in cell lines expressing wild-type β-catenin, NF-κB is involved in the APC-mediated modulation of HIF-1α. We depleted RelA in combination with APC by using siRNA. In HAβ85 cells, siRNA targeted against RelA and APC efficiently reduced RelA and APC protein by ∼50% ([Figure 6](#F6){ref-type="fig"}A). Importantly, codepletion of APC and RelA completely prevented the increase in HIF-1α mRNA achieved by APC depletion alone. Similar results were also obtained in U2OS cells (Supplemental Figure 6). Together, our data show that elevated wild-type β-catenin and the subsequent increase in NF-κB that result from APC depletion up-regulate the HIF-1α gene.

![Increased HIF-1α after APC depletion requires NF-κB. (A) HAβ85 cells were transfected with the indicated siRNA oligonucleotides for 48 h before RNA extraction. Where indicated, cells were exposed to 1% O2 for 24 h. RT-qPCR was performed for the levels of HIF-1α, RelA, and APC, with actin used as normalizing gene. Graph depicts the mean plus SD of a minimum of three independent experiments performed in duplicate. (B) HAβ85 and HAβ18 cells were treated with 1% O~2~ for 24 h before lysis. Whole cell lysates were analyzed by immunoblot for the levels of the indicated proteins. (C) HAβ85 and HAβ18 cells transfected with control and APC siRNA oligonucleotides for 48 h. Cells were exposed to 1% O~2~ for 24 h before harvest. Whole cell lysates were analyzed by Western blot using the indicated antibodies. Arrows indicate LC3I and LC3II. (D) HAβ85 and HAβ18 cells transfected with control and HIF-1α siRNA oligonucleotides for 48 h. Cells were exposed to 1% O~2~ for 24 h before harvest. Whole cell lysates were analyzed by Western blot using the indicated antibodies. Arrows indicate LC3I and LC3II. (E) Survival effects of APC and HIF-1α depletion in HAβ85 and HAβ18 cells. Cells were transfected with siRNA oligonucleotides for APC and HIF-1α as indicated. 24 h posttransfection, cells were counted and the indicated number of cells were plated and allowed to grow for additional 7 d before fixation and crystal violet staining. Plates were scanned and ImageJ software was used to count colonies.](zmk0211096350006){#F6}

APC Depletion Enhances HIF-1α--mediated Cellular Functions
----------------------------------------------------------

We confirmed the effect of deregulated β-catenin on HIF-1α protein by using the isogenic HCT-116 cell lines. Consistent with our mRNA data, we found cells with wild-type β-catenin have higher levels of HIF-1α compared with those with mutant β-catenin cells ([Figure 6](#F6){ref-type="fig"}B). This was mirrored by HIF-1α activity as indicated by elevated levels of Glut3 in wild-type cells ([Figure 6](#F6){ref-type="fig"}B).

Hypoxia induces several cellular changes, including autophagy ([@B21]). Autophagy is characterized by the formation of autophagosomes, which recycle damaged organelles such as mitochondria, and it can contribute to both cell survival and death ([@B22]; [@B46]). During autophagy, light chain 3 (LC3) proteins are cleaved from LC3I and LC3II forms, and the cleaved form associates with autophagosomes. The presence of LC3II on autophagosomes as well as its conversion to its cleaved form are indicators of autophagy ([@B30]).

Because our results suggested that APC depletion enhances HIF-1α levels, we next investigated whether this correlated with changes in levels of the autophagy marker LC3II. When APC was depleted in wild-type β-catenin cells that were exposed to hypoxic conditions, LC3II levels were higher than in control cells ([Figure 6](#F6){ref-type="fig"}C). However, in β-catenin mutant cells, depletion of APC failed to increase this autophagy marker ([Figure 6](#F6){ref-type="fig"}C). Nevertheless, mutant β-catenin cells when depleted of APC, still up-regulate Wnt target genes such as cyclin D1 ([Figure 6](#F6){ref-type="fig"}C). To determine the contribution of HIF-1α to hypoxia-induced autophagy, we depleted cells of HIF-1α before hypoxia exposure. In the absence of HIF-1α, hypoxia-induced cleavage of LC3 was greatly reduced ([Figure 6](#F6){ref-type="fig"}D). This is in accordance with previous studies where HIF-1α has been shown to play a prominent role in hypoxia-mediated autophagy ([@B47]; [@B44]; [@B26]; [@B28]). The effects of APC and HIF-1α in the two different cell lines also were confirmed using LC3 immunofluorescence (Figure S7). These results suggest that APC depletion enhances HIF-1α--mediated autophagy in cells with an intact APC--β-catenin regulatory pathway. In addition, we verified that APC and HIF-1α depletion resulted in increased survival, proliferation, or both in these cells ([Figure 6](#F6){ref-type="fig"}E). We found that APC depletion resulted in increased colony numbers only in cells with wild-type β-catenin. In contrast, HIF-1α depletion resulted in reduced colony formation in both cell types, even though the effect was more prominent in cells with wild-type β-catenin ([Figure 6](#F6){ref-type="fig"}E). These results demonstrate that the level of APC and HIF-1α directly affects the survival and proliferation of cells ([Figure 7](#F7){ref-type="fig"}).

![Summary diagram of key findings. HIF-1α represses the APC gene directly. APC-mediated repression of HIF-1α is indirect and requires wild-type APC, low levels of β-catenin, and NF-κB activity. \*, low levels of β-catenin allow for NF-κB activity and hence are not repressed. \*\*, mutations in β-catenin make this protein nondegradable and thus constitutively active. High levels of β-catenin prevent NF-κB activation.](zmk0211096350007){#F7}

DISCUSSION
==========

In this report, we uncovered an antagonistic relationship between the tumor suppressor APC and the hypoxia activated transcription factor HIF-1α, two important genes involved in development as well as in cancer progression and suppression. Although HIF-1α represses the APC gene directly, APC-mediated repression of HIF-1α relies on controlled changes in the levels of β-catenin and NF-κB.

We found that HIF-1α represses the APC gene directly via a functional HRE in the APC promoter ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} and Supplemental Figures 1 and 2). In this case, HIF-1α binding results in repression of APC mRNA and protein. This reveals an important mechanism for how hypoxia can promote cell survival. HIF-1α--repressive activities are not well understood. However, its ability to repress DNA repair genes such as MSH2 and MSH6 is established ([@B45]). Our data thus uncovered APC as a novel HIF-1α--repressed gene. We observed that hypoxia induced the repression of wild-type and mutant APC. The consequence of losing mutated APC in hypoxic tumor cells is not clear. It is possible that mutant APC has functions that are different from wild-type APC. However, such pathways have not been fully elucidated, but they may involve other aspects of APC biology such as cytoskeletal regulation. In the future, it will be necessary to investigate how non-Wnt--related processes mediated by APC are affected by inhibition of mutant APC after hypoxia.

A crucial function of APC in cells is to limit the amount of β-catenin available for transcriptional activation and this is induced by Wnt signaling. However, recent studies have shown that after inactivation of APC, nuclear accumulation of β-catenin occurs later and at more advanced stages of disease ([@B35]). Furthermore, β-catenin is not uniformly nuclear in cells lacking APC and also can be affected by other factors, including the extracellular matrix and p53 ([@B5]; [@B7]; [@B25]). This suggests that cytoplasmic β-catenin also may play a role in other signaling pathways that can contribute to cancer progression. Consistent with this idea, recent studies showed that β-catenin can alter NF-κB function ([@B9], [@B10]; [@B12]): whereas high levels of β-catenin (found in mutant APC or mutant β-catenin--expressing cells) inhibit NF-κB activity, cells with low levels of β-catenin have normal NF-κB activity ([@B12]). We were able to reproduce these results using HCT-116 cell lines that express either wild-type or mutated (stabilized) β-catenin (Supplemental Figure 5). Our data indicate that depletion of APC in cells with wild-type β-catenin leads to NF-κB--mediated activation of the HIF-1α gene. Although paradoxical (because the elevated levels of β-catenin that result from inactivation of APC are expected to inhibit NF-κB), this observation might explain why inhibition of APC alone does not immediately give rise to malignant tumors. In this scenario, the elevated levels of HIF-1α could exert a protective effect against tumorigenesis as observed in mouse models of chemical induced carcinogenesis ([@B42]). Furthermore, HIF-1α can control β-catenin function ([@B19]) and inhibit a variety of TCF4 target genes, including c-myc and cyclin D1 ([@B24]). This means that even after inhibition of APC, the resulting upregulation of HIF-1α could delay Wnt signaling effects. However, the situation can be reversed after prolonged lack of APC or in the presence of constitutively high levels of β-catenin. In fact, in cells acclimatized to APC inhibition or with high levels of β-catenin, HIF-1α promotes Xenograft growth ([@B8]). In this context, it is noteworthy that although cells that express only mutant β-catenin do not up-regulate HIF-1α to the same extent as wild-type β-catenin--expressing cells when depleted of APC ([Figure 6](#F6){ref-type="fig"}B), they still up-regulate Wnt target genes such as cyclin D1 ([Figure 6](#F6){ref-type="fig"}C) and they respond with a measurable, albeit smaller, increase in β-catenin transcriptional activity. This may be due to a loss of APC from the cytoplasm where it could normally act to sequester β-catenin. Significantly, we show that in the context of a tissue, depletion of APC results in increased HIF-1α activity ([Figure 4](#F4){ref-type="fig"}A), thus establishing a setting for our findings at an organism level.

The dual role of NF-κB as either a tumor suppressor or an oncogene has been extensively described previously ([@B33]). We found that depleting APC leads to NF-κB--mediated activation of HIF-1α, whereas other studies showed that APC overexpression can activate NF-κB ([@B10]). A more detailed analysis of the relative activity of these different molecules at different stages of tumor progression is needed to determine how the balance of APC, β-catenin, and NF-κB contributes to tumorigenesis. Importantly, our results suggest that prolonged hypoxia can induce oncogenic changes in tumors that retain wild-type APC and β-catenin.
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